Revance Therapeutics, Inc. financial data

Symbol
RVNC on Nasdaq
Industry
Pharmaceutical Preparations
Location
1222 Demonbreun Street, Suite 2000, Nashville, TN
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 433 % -12.1%
Quick Ratio 63 % +95%
Debt-to-equity -514 % -136%
Return On Equity 237 %
Return On Assets -57.1 % +2.68%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105M shares +19.2%
Common Stock, Shares, Outstanding 105M shares +19.2%
Entity Public Float 2.2B USD +120%
Common Stock, Value, Issued 105K USD +19.3%
Weighted Average Number of Shares Outstanding, Basic 104M shares +24.1%
Weighted Average Number of Shares Outstanding, Diluted 104M shares +24.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 251M USD +40.2%
Research and Development Expense 74.5M USD -7.74%
Operating Income (Loss) -295M USD +9.2%
Income Tax Expense (Benefit) 300K USD -57.1%
Net Income (Loss) Attributable to Parent -288M USD +19.6%
Earnings Per Share, Basic -3.23 USD/shares +30.1%
Earnings Per Share, Diluted -3.23 USD/shares +30.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 81.5M USD -42.3%
Cash, Cash Equivalents, and Short-term Investments 232M USD -27.4%
Accounts Receivable, after Allowance for Credit Loss, Current 36.1M USD +112%
Inventory, Net 68.3M USD +98.2%
Assets, Current 350M USD -7.59%
Property, Plant and Equipment, Net 16.7M USD +31.3%
Operating Lease, Right-of-Use Asset 49.7M USD +44.5%
Intangible Assets, Net (Excluding Goodwill) 8.18M USD -71.3%
Goodwill 0 USD -100%
Other Assets, Noncurrent 296K USD -93.7%
Assets 495M USD -17.2%
Accounts Payable, Current 4.99M USD -40.3%
Employee-related Liabilities, Current 21.2M USD +19.5%
Accrued Liabilities, Current 47.2M USD +19.3%
Contract with Customer, Liability, Current 9.61M USD +76.9%
Liabilities, Current 93.6M USD +26.4%
Contract with Customer, Liability, Noncurrent 68M USD -17.3%
Operating Lease, Liability, Noncurrent 36.9M USD +18.1%
Other Liabilities, Noncurrent 2.91M USD +2.68%
Liabilities 625M USD +9.42%
Accumulated Other Comprehensive Income (Loss), Net of Tax -26K USD +57.4%
Retained Earnings (Accumulated Deficit) -2.17B USD -15.3%
Stockholders' Equity Attributable to Parent -130M USD -584%
Liabilities and Equity 495M USD -17.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -65.9M USD +5.12%
Net Cash Provided by (Used in) Financing Activities 92.8M USD +2743%
Net Cash Provided by (Used in) Investing Activities -31.7M USD -133%
Common Stock, Shares Authorized 190M shares 0%
Common Stock, Shares, Issued 105M shares +19.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.82M USD -117%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 88.5M USD -40.5%
Deferred Tax Assets, Valuation Allowance 496M USD +15.9%
Deferred Tax Assets, Gross 514M USD +17.1%
Operating Lease, Liability 43.3M USD +18.6%
Payments to Acquire Property, Plant, and Equipment 1.71M USD +96.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -287M USD +19.6%
Lessee, Operating Lease, Liability, to be Paid 59.9M USD +24.6%
Property, Plant and Equipment, Gross 37.2M USD -22.5%
Operating Lease, Liability, Current 6.39M USD +21.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.2M USD +24.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.9M USD +24.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.5M USD +43.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.54M USD -50.9%
Deferred Tax Assets, Operating Loss Carryforwards 377M USD +13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 12.9M USD +32.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.02M USD +58.6%
Operating Lease, Payments 2.56M USD +22.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.13M USD -65.5%
Depreciation, Depletion and Amortization 1.98M USD -53.9%
Deferred Tax Assets, Net of Valuation Allowance 18.6M USD +59.3%
Share-based Payment Arrangement, Expense 39.5M USD -25.6%
Interest Expense 20.1M USD +5.65%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%